Advertisement
Advertisement
U.S. markets open in 4 hours 7 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Sema4 Holdings Corp. (SMFR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
0.4142-0.0335 (-7.48%)
At close: 04:00PM EST
0.4300 +0.02 (+3.81%)
Pre-Market: 04:07AM EST
Advertisement

Sema4 Holdings Corp.

North Tower
8th Floor 333 Ludlow Street
Stamford, CT 06902
United States
800 298 6470
https://www.sema4.com

Sector(s)Healthcare
IndustryHealth Information Services
Full Time Employees1,200

Key Executives

NameTitlePayExercisedYear Born
Mr. Jason RyanExec. Chair of the Board30kN/A1974
Mr. Isaac RoConsultant541.99kN/AN/A
Ms. Katherine A. StuelandCEO & DirectorN/AN/A1976
Mr. Kevin FeeleySr. VP of Operations & CFON/AN/AN/A
Mr. Robert Sebra Ph.D.VP of Technology Devel.N/AN/AN/A
Dr. Matthew Davis Ph.D.Chief Technology & Product OfficerN/AN/AN/A
Dr. Gustavo Stolovitzky Ph.D.Chief Science OfficerN/AN/AN/A
Mr. Murali ManiChief Compliance & Privacy OfficerN/AN/AN/A
Mr. Joel Harrison KaufmanVP of Fin. & Corp. Devel.N/AN/A1989
Ms. Karen WhiteChief People OfficerN/AN/A1971
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle, as well as analytics for actionable insights, pre-clinical and clinical trial support, and advanced sequencing services. It also offers Sema4 Signal that enables and advances precision oncology care, from prevention to treatment to remission; and testing for carrier screening, noninvasive prenatal testing, and newborn screening, as well as hereditary cancer testing. In addition, the company provides COVID-19 testing solutions. Sema4 Holdings Corp. was incorporated in 2020 and is headquartered in Stamford, Connecticut.

Corporate Governance

Sema4 Holdings Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement